Examines issues surrounding the 2003 discovery of a case of bovine spongiform encephalopathy (BSE), also known as "mad cow disease," in a Washington State dairy cow. Reviews economic and trade implications of BSE case and U.S. BSE safeguards, including USDA and FDA policy changes after Washington State BSE case, provides an overview of international panel of BSE experts report assessing and recommending improvements for U.S. BSE safeguards, discusses a BSE case in Canada, including USDA response, and examines related 108th Congress legislative activities.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Nov. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report.
Microfiche version: Library of Congress. Congressional Research Service. Mad Cow Disease